307 related articles for article (PubMed ID: 28940102)
1. MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential.
Shah P; Bristow MR; Port JD
Curr Heart Fail Rep; 2017 Dec; 14(6):454-464. PubMed ID: 28940102
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device.
Morley-Smith AC; Mills A; Jacobs S; Meyns B; Rega F; Simon AR; Pepper JR; Lyon AR; Thum T
Eur J Heart Fail; 2014 Aug; 16(8):871-9. PubMed ID: 24961598
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Molecular Comparison of Pediatric and Adult Reverse Remodeling With Ventricular Assist Devices.
Weia BC; Adachi I; Jacot JG
Artif Organs; 2015 Aug; 39(8):691-700. PubMed ID: 25865791
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNAs in cardiac remodeling and heart failure.
Topkara VK; Mann DL
Cardiovasc Drugs Ther; 2011 Apr; 25(2):171-82. PubMed ID: 21431305
[TBL] [Abstract][Full Text] [Related]
5. Restoration of myocardial beta-adrenergic receptor signaling after left ventricular assist device support.
Pandalai PK; Bulcao CF; Merrill WH; Akhter SA
J Thorac Cardiovasc Surg; 2006 May; 131(5):975-80. PubMed ID: 16678578
[TBL] [Abstract][Full Text] [Related]
6. Recovery from heart failure with circulatory assist: a working group of the National, Heart, Lung, and Blood Institute.
Reinlib L; Abraham W;
J Card Fail; 2003 Dec; 9(6):459-63. PubMed ID: 14966786
[TBL] [Abstract][Full Text] [Related]
7. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
[TBL] [Abstract][Full Text] [Related]
8. Heterotopic Abdominal Rat Heart Transplantation as a Model to Investigate Volume Dependency of Myocardial Remodeling.
Benke K; Sayour AA; Mátyás C; Ágg B; Németh BT; Oláh A; Ruppert M; Hartyánszky I; Szabolcs Z; Radovits T; Merkely B; Szabó G
Transplantation; 2017 Mar; 101(3):498-505. PubMed ID: 27906830
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs in cardiac remodeling and heart failure.
Kumarswamy R; Thum T
Circ Res; 2013 Aug; 113(6):676-89. PubMed ID: 23989712
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of microRNAs in cardiac remodeling and heart failure.
Divakaran V; Mann DL
Circ Res; 2008 Nov; 103(10):1072-83. PubMed ID: 18988904
[TBL] [Abstract][Full Text] [Related]
11. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support.
Yang KC; Yamada KA; Patel AY; Topkara VK; George I; Cheema FH; Ewald GA; Mann DL; Nerbonne JM
Circulation; 2014 Mar; 129(9):1009-21. PubMed ID: 24429688
[TBL] [Abstract][Full Text] [Related]
12. Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support.
Schipper ME; van Kuik J; de Jonge N; Dullens HF; de Weger RA
J Heart Lung Transplant; 2008 Dec; 27(12):1282-5. PubMed ID: 19059107
[TBL] [Abstract][Full Text] [Related]
13. The Effects of MicroRNAs in the Development of Heart Failure.
Guo YT; Xiao YC; Xu YL; Fan JF; Niu LY; Tan X; Wang YK
Curr Cardiol Rep; 2023 Jul; 25(7):747-759. PubMed ID: 37233923
[TBL] [Abstract][Full Text] [Related]
14. Myocardial recovery and the failing heart: medical, device and mechanical methods.
Goldfinger JZ; Nair AP
Ann Glob Health; 2014; 80(1):55-60. PubMed ID: 24751565
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Delivery of miR-148a Suppresses Ventricular Dilation in Heart Failure.
Raso A; Dirkx E; Philippen LE; Fernandez-Celis A; De Majo F; Sampaio-Pinto V; Sansonetti M; Juni R; El Azzouzi H; Calore M; Bitsch N; Olieslagers S; Oerlemans MIFJ; Huibers MM; de Weger RA; Reckman YJ; Pinto YM; Zentilin L; Zacchigna S; Giacca M; da Costa Martins PA; López-Andrés N; De Windt LJ
Mol Ther; 2019 Mar; 27(3):584-599. PubMed ID: 30559069
[TBL] [Abstract][Full Text] [Related]
16. Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle.
Malliaras KG; Terrovitis JV; Drakos SG; Nanas JN
J Cardiovasc Transl Res; 2009 Mar; 2(1):114-25. PubMed ID: 20559975
[TBL] [Abstract][Full Text] [Related]
17. Myocardial microRNAs associated with reverse remodeling in human heart failure.
Sucharov CC; Kao DP; Port JD; Karimpour-Fard A; Quaife RA; Minobe W; Nunley K; Lowes BD; Gilbert EM; Bristow MR
JCI Insight; 2017 Jan; 2(2):e89169. PubMed ID: 28138556
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as theranostic markers in cardiac allograft transplantation: from murine models to clinical practice.
Novák J; Macháčková T; Krejčí J; Bienertová-Vašků J; Slabý O
Theranostics; 2021; 11(12):6058-6073. PubMed ID: 33897899
[TBL] [Abstract][Full Text] [Related]
19. Expression of follistatin-related genes is altered in heart failure.
Lara-Pezzi E; Felkin LE; Birks EJ; Sarathchandra P; Panse KD; George R; Hall JL; Yacoub MH; Rosenthal N; Barton PJ
Endocrinology; 2008 Nov; 149(11):5822-7. PubMed ID: 18617621
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular assist device-induced molecular changes in the failing myocardium.
Soppa GK; Barton PJ; Terracciano CM; Yacoub MH
Curr Opin Cardiol; 2008 May; 23(3):206-18. PubMed ID: 18382208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
